Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon Raises $8M in Series B Funding

NEW YORK, Jan. 18 (GenomeWeb News) - Metabolon closed an $8 million Series B funding round, the company said today.

 

Investors in this round included Sevin Rosen Funds, Aurora Funds, and Trelys Funds. Harris & Harris Group participated as a new investor, contributing $2.5 million.

 

Metabolon, based in Research Triangle Park, NC, uses metabolomics to discover biomarkers. The company has ongoing biomarker-discovery collaborations with the National Cancer Institute, the Amyotrophic Lateral Sclerosis Association, and the US Centers for Disease Control and Prevention, among others.

 

The company raised $9 million in Series A funding in October 2004.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.